Our industry-leading neuroscience portfolio includes FDA-approved treatments for major depressive disorder, agitation associated with dementia due to Alzheimer's disease, excessive daytime sleepiness associated with narcolepsy and obstructive sleep apnea, and migraine, as well as multiple novel product candidates addressing a broad range of serious neurological and psychiatric conditions that impact over 150 million people in the United States. Assist and coordinate tax compliance tasks with external tax accountants, including providing required information for periodic tax reporting, and annual tax returns for federal, state, and local governments, international countries, and reviewing supporting tax schedules and filings.